About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesCipla Limited10.010324000036.2712
Domestic EquitiesSMS Pharmaceuticals Limited9.5830111864734.7228
Domestic EquitiesSequent Scientific Limited8.5014147712630.8040
Domestic EquitiesZydus Wellness Ltd8.051364173029.1730
Domestic EquitiesAster DM Healthcare Limited7.604244667127.5529
Domestic EquitiesAurobindo Pharma Limited7.094621730025.7066
Domestic EquitiesPfizer Ltd6.60104795423.9180
Domestic EquitiesAlivus Life Sciences6.230524629822.5757
Domestic EquitiesANTHEM BIOSCIENCES LIMITED5.997433355421.7310
Domestic EquitiesAdani Enterprises Limited5.87199499621.2763
Domestic EquitiesSamvardhana Motherson International Ltd4.0919123615014.8264
Domestic EquitiesDivi's Laboratories Limited3.60332042413.0560
Domestic EquitiesConcord Biotech Limited3.09998347211.2320
Domestic EquitiesGland Pharma Limited1.3343280764.8347
Total 87.6749 317.6806
Cash & Cash Equivalents and Net AssetsTREPS 01-Jan-2026 DEPO 104.26921546915.4691
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-9.6616 -35.0077
Total -5.3923 -19.5386
Treasury Bills182 Days Treasury Bill 29-Jan-20261.92417000006.9719
Treasury Bills91 Days Treasury Bill 02-Jan-20260.82783000002.9996
Treasury Bills91 Days Treasury Bill 15-Jan-20260.82633000002.9940
Treasury Bills91 Days Treasury Bill 26-Feb-20260.82143000002.9763
Treasury Bills91 Days Treasury Bill 23-Jan-20260.55022000001.9936
Treasury Bills91 Days Treasury Bill 27-Mar-20260.54542000001.9761
Treasury Bills91 Days Treasury Bill 06-Feb-20260.27451000000.9948
Treasury Bills91 Days Treasury Bill 05-Mar-20260.27351000000.9911
Total 6.0433 21.8974
Derivatives-FuturesDivi's Laboratories Limited 27/01/20262.92711650010.6062
Derivatives-FuturesBiocon Ltd 27/01/20262.868126250010.3924
Derivatives-FuturesApollo Hospitals Enterprise Ltd 27/01/20262.3476120008.5062
Derivatives-FuturesAurobindo Pharma Limited 27/01/20261.6792511506.0843
Derivatives-FuturesTech Mahindra Limited 27/01/20261.4306324005.1837
Total 11.2527 40.7728
RightsAdani Enterprises Limited PP RE0.4215113991.5271
Total 0.4215 1.5271
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.